This document applies to molecular in vitro diagnostic (IVD) examinations, including laboratory-developed tests (LDTs) performed in medical and molecular pathology laboratories. It is intended for laboratory customers, IVD developers and manufacturers, biobanks, research institutions, commercial organizations, and regulatory authorities. Additionally, it acknowledges that international, national, or regional regulations may apply to specific topics covered in this document.